Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
life sciences
national blog main
national top stories
4
×
new york blog main
4
×
san francisco blog main
clinical trials
new york top stories
san diego blog main
san francisco top stories
biotech
bristol-myers squibb
gene therapy
pfizer
san diego top stories
allergan
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biomarin
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
breast
cancer
celgene
clinical data
combinations
conference
detroit blog main
detroit top stories
duchenne muscular dystrophy
dyne therapeutics
esmo
esmo 2018
european society for medical oncology
facioscapulohumeral muscular dystrophy
What
data
4
×
drug
medical
ago
annual
approved
biotechs
breast
cancer
cancer's
clinical
close
conference
considering
disease
diseases
dyne
early
esmo
european
expected
experimental
eyes
fatty
forward
gene
genetic
having
heated
hemophilia
horizon
humans
intercept
ipo
ipos
known
lines
liver
long
lung
Language
unset
Current search:
data
×
" national top stories "
×
" new york blog main "
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front